LUM and tularemia: While LAOdcs are long-recognised as drug targets, and development of specific mechanism-based Ldc inhibitors is an active research field69–72, we envision that the LdcF structure and the functional findings presented in this work will empower further investigations aimed at design of new LdcF-based therapeutic approaches against tularemia.